In an early study of MM that utilized scRNA-seq on patient-derived BME samples (CD138− or CD45+ cell populations) from patients with MGUS, low-risk or high-risk SMM, and active MM, the authors revealed early alterations in immune cell composition at the precursor stages, with substantial T cells enrichment in particular [39]. The gene discussed is SDC1; the disease is Miyoshi myopathy.